July 15, 2020 — The U.S. Food and Drug Administration (FDA) granted clearance for the Edwards Lifesciences Corp. Konect Resilia aortic valved conduit (AVC), the first ready-to-implant solution for bio-Bentall procedures, a complex surgery that involves replacement of a patient's aortic valve...
has anyone read the above or talked to their cardio about it? Seems like a pretty big announcement/advancement, no?
wonder if anyone more knowledgeable about this condition can explain what this could mean for the future of bav patients? Specifically when it comes to choosing mechanical vs tissue.